|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finding multiple mutations in cancer: science vs the media Medscape Share ![]() ![]() ![]() ![]() Nationally renowned oncologist Dr. Maurie Markman, national director for medical oncology at Cancer Treatment Centers of America, discusses a paper found in the New England Journal of Medicine, titled: "Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing." According to Markman, "The paper demonstrated ... that within an individual cancer — and even an individual mass in that cancer — one can see multiple patterns, mutations, and pathways that are arranged in an abnormal manner. Of course, we must be concerned about the impact of this heterogeneity on outcome." More
FDA approves additional blood test for viruses linked to leukemia, neurologic diseases U.S. Food and Drug Administration Share ![]() ![]() ![]() ![]() Avioq HTLV-I/II Microelisa System, a test designed to detect antibodies to viruses in donors of human blood and blood components that are associated with several diseases, including some forms of leukemia and neurologic diseases, was approved by the U.S. Food and Drug Administration. Avioq HTLV-I/II Microelisa System, is the only test now available that can be used to both screen the blood supply for antibodies to Human T-Lymphotropic Virus Type I (HTLV-I) and Human T-Lymphotropic Virus Type II (HTLV-II), and help diagnose infection with these viruses. More New breast cancer susceptibility gene ScienceDaily Share ![]() ![]() ![]() ![]() Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes. More Tiny reader makes fast, cheap DNA sequencing feasible Lab Manager Magazine Share ![]() ![]() ![]() ![]() Researchers have devised a nanoscale sensor to electronically read the sequence of a single DNA molecule, a technique that is fast and inexpensive and could make DNA sequencing widely available. The technique could lead to affordable personalized medicine, potentially revealing predispositions for afflictions such as cancer, diabetes or addiction. More
House passes budget plan shaking up Medicare, Medicaid Medscape Medical News Share ![]() ![]() ![]() ![]() In the wake of the Supreme Court hearings on the Affordable Care Act that left its survival in doubt, the GOP-controlled House yesterday approved a budget that would repeal healthcare reform and partially privatize Medicare. The measure comfortably passed in a 228-191 vote, but it faces impossible odds in a Democrat-controlled Senate, and a veto-wielding White House already has given it a failing grade. More HEDIS data provides evidence that physicians are more effective in using clinical pathology laboratory tests improve patient care Dark Daily Share ![]() ![]() ![]() ![]() For almost a decade now, clinical laboratories and pathology groups have been asked by many private payers to provide laboratory test data for a number of clinical services. In turn, these private health insurers annually submit this data to the Healthcare Effectiveness Data and Information Set (HEDIS) program managed by the National Committee for Quality Assurance. More Legos helps build synthetic bones Laboratory Equipment Share ![]() ![]() ![]() ![]() Engineering isn't all glamor. In the course of devising and producing the stuff that improves all our lives, the lab often becomes home to laborious procedures that can start to sap the strength of even the hardiest engineers. More
Lab and pathologist collaboration Advance for Administrators of the Laboratory Share ![]() ![]() ![]() ![]() Financial incentives alone won't create collaboration. Laboratory management and pathologists must build trust and the ability to collaborate before entering into new contractual arrangements. Good partners create good partnerships, not the other way around. More Trends in salary, compensation, and benefits is nation's oldest for medical laboratory CEOs, executives and administrators Dark Daily Share ![]() ![]() ![]() ![]() For the fourth consecutive year, a reliable national survey of compensation trends for clinical laboratory executives, administrators, directors, pathologists and managers was conducted. The first findings of this survey will be presented on May 1 at the Executive War College on Laboratory and Pathology Management in New Orleans. More
Hepatitis E infected more than 20 million worldwide annually Medscape Medical News Share ![]() ![]() ![]() ![]() An estimated 20.1 million people in 9 regions of Africa and Asia were infected with hepatitis E virus (HEV) in 2005, according to a study published in Hepatology. HEV is an enterically transmitted RNA virus that can cause outbreaks or sporadic disease, and large outbreaks are typical in developing countries with contaminated water. More 11 telemedicine tools transforming healthcare InformationWeek Share ![]() ![]() ![]() ![]() What's fueling the healthcare industry's interest in telemedicine? Better mobile technologies and more mature electronic health records (EHRs) and clinical decision support systems lead the list. Also, as the baby boomer generation ages, medical expert shortages arise in many specialties. More
US requires new dual-use biological research reviews ScienceInsider Share ![]() ![]() ![]() ![]() The U.S. government released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 "high consequence" pathogens and toxins, including the H5N1 avian influenza virus. The reviews are designed to reduce the risks associated with "dual use research of concern" that could be used for good or evil. More A blood test without bleeding medGadget via The Atlantic Share ![]() ![]() ![]() ![]() In this video news brief, from TED2012, TED fellow Myshkin Ingawale gave a talk on how he helped to develop a prick-free blood hemoglobin measurement device. His technology, conceived after 32 tries, seems to focus specifically on the developing world where cost and access are serious problems. More
In cancer science, many 'discoveries' don't hold up Reuters via Medscape Share ![]() ![]() ![]() ![]() A former researcher at Amgen Inc says many basic studies on cancer -- a high proportion of them from university labs -- are unreliable, with grim consequences for producing new medicines in the future. More Key enzyme involved in protecting nerves from degeneration identified ScienceDaily Share ![]() ![]() ![]() ![]() A new animal model of nerve injury has brought to light a critical role of an enzyme called Nmnat in nerve fiber maintenance and neuroprotection. Understanding biological pathways involved in maintaining healthy nerves and clearing away damaged ones may offer scientists targets for drugs to mitigate neurodegenerative diseases such as Huntington's and Parkinson's, as well as aid in situations of acute nerve damage, such as spinal cord injury. More
Robots will be able to feel sooner than you think SmartPlanet Share ![]() ![]() ![]() ![]() In a recent paper published in Advanced Functional Materials, a team of researchers from the University of Pittsburgh and the Massachusetts Institute of Technology have demonstrated the use of a nonoscillating gel that can be resuscitated in a similar manner to medical cardiopulmonary resuscitation. In the same way that human skin provides signals to the brain when there is an external pressure, pain or environmental change, the Belousov-Zhabotinsky gel (first developed in the 1990s) could become the "holy grail" of robotics — by functioning as a sensory, artificial skin. More Collecting cancer data The Scientist Share ![]() ![]() ![]() ![]() The Broad Institute and Sanger Institute announced details from their separate cancer cell line databases, the largest such repositories of genomic and drug profiling data to date. With preliminary results published in two Nature papers, the databases should help researchers identify which drugs to use against which cancers to streamline drug development efforts. More |
![]() ![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|